Avoiding vicious circles - Mineralocorticoid receptor antagonism prevents vascular oxidative stress early after myocardial infarction

被引：2
|
作者：
Brandes, Ralf P. [1 ]
机构：
[1] Univ Frankfurt, Fachbereich Med, Inst Kardiovask Physiol, D-60596 Frankfurt, Germany
来源：
HYPERTENSION | 2007年 / 50卷 / 05期
关键词：
D O I：
10.1161/HYPERTENSIONAHA.107.098699
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：842 / 843
页数：2
相关论文
共 50 条
  • [1] Mineralocorticoid receptor blockade improves vasomotor dysfunction and vascular oxidative stress early after myocardial infarction
    Sartorio, Carmem Luiza
    Fraccarollo, Daniela
    Galuppo, Paolo
    Leutke, Meike
    Ertl, Georg
    Stefanon, Ivanita
    Bauersachs, Johann
    HYPERTENSION, 2007, 50 (05) : 919 - 925
  • [2] Mineralocorticoid receptor antagonism prevents the electrical remodeling that precedes cellular hypertrophy after myocardial infarction
    Perrier, E
    Kerfant, BG
    Lalevee, N
    Bideaux, P
    Rossier, MF
    Richard, S
    Gómez, AM
    Benitah, JP
    CIRCULATION, 2004, 110 (07) : 776 - 783
  • [3] Mineralocorticoid receptor antagonism attenuates cardiac hypertrophy and prevents oxidative stress in uremic rats
    Michea, Luis
    Villagran, Andrea
    Urzua, Alvaro
    Kuntsmann, Sonia
    Venegas, Patricio
    Carrasco, Loreto
    Gonzalez, Magdalena
    Marusic, Elisa T.
    HYPERTENSION, 2008, 52 (02) : 295 - 300
  • [4] Mineralocorticoid Receptor Antagonism in Acute Myocardial Infarction Who Benefits?
    Weir, Robin A. P.
    Petrie, Colin J.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 68 (20) : 2240 - 2241
  • [5] Increased angiogenesis and reduced infarct expansion by immediate mineralocorticoid receptor antagonism after myocardial infarction
    Bauersachs, J.
    Fraccarollo, D.
    Galuppo, P.
    Ertl, G.
    EUROPEAN HEART JOURNAL, 2006, 27 : 350 - 350
  • [6] REPLY: Mineralocorticoid Receptor Antagonism in Acute Myocardial Infarction Who Benefits?
    Beygui, Farzin
    Montalescot, Gilles
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 68 (20) : 2241 - 2242
  • [7] The selective aldosterone receptor antagonist eplerenone improves vasomotor dysfunction and vascular oxidative stress early after myocardial infarction
    Sartorio, CL
    Fraccarollo, D
    Leutke, M
    Bauersachs, J
    CIRCULATION, 2005, 112 (17) : U318 - U318
  • [8] Efficacy of mineralocorticoid receptor antagonism in the acute myocardial infarction phase: eplerenone versus spironolactone
    Fraccarollo, Daniela
    Galuppo, Paolo
    Sieweke, Jan-Thorben
    Napp, L. Christian
    Grobbecker, Paul
    Bauersachs, Johann
    ESC HEART FAILURE, 2015, 2 (03): : 150 - 158
  • [9] Mineralocorticoid Receptor Antagonism Treatment for All PatientsWith ST-Segment Myocardial Infarction?
    Weir, Robin A. P.
    JAMA INTERNAL MEDICINE, 2018, 178 (11) : 1567 - 1567
  • [10] Mineralocorticoid Receptor Antagonism Prevents Vascular Remodeling in Mesenteric Arteries of Mice with type 2 Diabetes
    Silva, Marcondes A.
    Cau, Stefany B.
    Manzato, Carla P.
    Touyz, Rhian M.
    Tostes, Rita C.
    HYPERTENSION, 2013, 62 (03)
12345